LifePoint Health (LPNT) Misses Q2 EPS by 19c, Guidance Falls Short

Go back to LifePoint Health (LPNT) Misses Q2 EPS by 19c, Guidance Falls Short

Wedbush Cuts Price Target on LifePoint Health (LPNT) to $66 Following 2Q; Reiterates Neutral

August 1, 2016 8:06 AM EDT

Wedbush maintained a Neutral rating on Lifepoint Holdings (NASDAQ: LPNT), and cut the price target to $66.00 (from $80.00), following the company's 2Q.

Analyst Sarah James commented, "Admission trends have been disappointing across the board for hospitals. The drivers seem relatively company specific in... More

Mizuho Securities Remains Neutral as LifePoint Health (LPNT) Trades Below Previous Target - PT to $56

August 1, 2016 7:06 AM EDT

Mizuho Securities maintained a Neutral rating on Lifepoint Holdings (NASDAQ: LPNT), and cut the price target to $56.00 (from $61.50), following the company's 2Q. Mizuho attributes the company's recent trade down and guide cut to one-time issues involving a flawed too-rapid acquisition strategy.

Analyst Sheryl... More